newsfilter
← Latest News
GlobeNewswire·

Graybug Vision Reports Full Year 2021 Financial Results and Recent Corporate Developments

BALTIMORE, March 10, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (NASDAQ:GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today provided an update on recent corpora